Multiple sclerosis is often diagnosed in patients who are planning on having children.
Although multiple sclerosis does not negatively influence most pregnancy outcomes, less is …

Objective: The objective of this study was to develop evidence-based recommendations on
pregnancy management for persons with multiple sclerosis (MS). Background: MS typically …

Objective To summarize the available literature and provide an overview of in utero
exposure to maternal multiple sclerosis (MS) and the influence on offspring health …

Introduction Interferon beta (IFN beta) preparations are an established group of drugs used
for immunomodulation in patients with multiple sclerosis (MS). Subcutaneously (sc) applied …

Abstract Background and Objectives There is a lack of well-controlled US studies of
intramuscular (IM) interferon beta (IFNβ)-1a use in pregnant women with multiple sclerosis; …

Multiple sclerosis (MS) is a chronic, progressive, inflammatory disorder of the central
nervous system. Relapsing–remitting MS (RRMS), the most common form of the disease, is …

Background: Based on data from two large cohort studies, a label update became
applicable for the class of interferon beta therapies in 9/2019, allowing interferons during …

Objectives To report pregnancy outcomes among multiple sclerosis (MS) patients treated
with disease-modifying therapies (DMTs). Methods We performed a retrospective chart …

Background: Mothers with multiple sclerosis are at increased risk of preterm birth and small
for gestational age infants. Both conditions pose a risk of morbidity, including early-life …

Introdução: As mulheres podem ser acometidas pela esclerose múltipla, doença autoimune,
cujos surtos neurológicos podem levar à incapacitação, fazendo com que a decisão de …